HCV 'Cure' Now on Agenda

BOSTON -- The possibility of making even the most refractory subtypes of hepatitis C routinely curable is coming closer, a prominent researcher said in this exclusive InFocus interview.

Arun Sanyal, MD, president of the American Association for the Study of Liver Diseases, reviewed some of the new data with MedPage Today North American Correspondent Michael Smith at the association's annual meeting. As part of the discussion, Sanyal explained why he thinks hepatitis C will soon be a "winnable" disease.

Medpage Today: http://medpagetoday.com
Online CME - Continuing medical education: http://www.medpagetoday.com/cme/
Latest medical news: http://www.medpagetoday.com/latest/

The MedPage Today app:
iOS: https://goo.gl/JKrkHq
Android: https://play.google.com/store/apps/de...

MedPage Today Youtube Channel: https://www.youtube.com/user/MedPageT...
Medpage Today on Facebook: https://www.facebook.com/MedPageToday

• Category

  • News & Politics

• License

  • Standard YouTube License